| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 16 | 2025 | 707 | 2.900 |
Why?
|
| Delivery of Health Care | 8 | 2021 | 395 | 2.210 |
Why?
|
| Humans | 75 | 2025 | 17376 | 1.960 |
Why?
|
| Terminal Care | 4 | 2021 | 46 | 1.950 |
Why?
|
| Delivery of Health Care, Integrated | 9 | 2025 | 537 | 1.780 |
Why?
|
| Advance Care Planning | 4 | 2021 | 21 | 1.530 |
Why?
|
| Internship and Residency | 2 | 2022 | 48 | 1.530 |
Why?
|
| Diagnostic Errors | 4 | 2022 | 30 | 1.450 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2019 | 185 | 1.420 |
Why?
|
| Quality Improvement | 7 | 2025 | 190 | 1.380 |
Why?
|
| Patient Preference | 3 | 2021 | 49 | 1.380 |
Why?
|
| Colonic Neoplasms | 3 | 2022 | 163 | 1.330 |
Why?
|
| Physicians | 3 | 2021 | 128 | 1.240 |
Why?
|
| Colorectal Neoplasms | 5 | 2022 | 627 | 1.220 |
Why?
|
| California | 23 | 2025 | 2317 | 1.190 |
Why?
|
| Attitude of Health Personnel | 6 | 2025 | 200 | 1.180 |
Why?
|
| Mass Screening | 7 | 2025 | 671 | 1.160 |
Why?
|
| Quality of Health Care | 6 | 2022 | 279 | 1.160 |
Why?
|
| Male | 38 | 2025 | 9843 | 1.120 |
Why?
|
| Health Services Research | 3 | 2017 | 212 | 1.050 |
Why?
|
| Program Evaluation | 3 | 2017 | 215 | 1.010 |
Why?
|
| Creatinine | 2 | 2017 | 66 | 1.000 |
Why?
|
| Female | 37 | 2025 | 12444 | 0.970 |
Why?
|
| Physician-Patient Relations | 3 | 2016 | 169 | 0.940 |
Why?
|
| Aged | 29 | 2023 | 6129 | 0.940 |
Why?
|
| Patient Satisfaction | 5 | 2019 | 198 | 0.940 |
Why?
|
| Drug Prescriptions | 4 | 2023 | 148 | 0.850 |
Why?
|
| Practice Guidelines as Topic | 6 | 2019 | 311 | 0.850 |
Why?
|
| Patient Readmission | 3 | 2017 | 165 | 0.840 |
Why?
|
| Hypertension | 5 | 2015 | 469 | 0.820 |
Why?
|
| Preventive Health Services | 2 | 2016 | 152 | 0.820 |
Why?
|
| Continuity of Patient Care | 2 | 2015 | 104 | 0.820 |
Why?
|
| Water Sports | 1 | 2022 | 1 | 0.810 |
Why?
|
| Patient Portals | 2 | 2021 | 23 | 0.810 |
Why?
|
| Professional Competence | 2 | 2013 | 11 | 0.810 |
Why?
|
| Middle Aged | 30 | 2025 | 7885 | 0.790 |
Why?
|
| Malpractice | 1 | 2022 | 12 | 0.780 |
Why?
|
| Education, Medical | 1 | 2022 | 15 | 0.780 |
Why?
|
| Glomerular Filtration Rate | 3 | 2019 | 153 | 0.770 |
Why?
|
| Managed Care Programs | 2 | 2014 | 309 | 0.750 |
Why?
|
| Aged, 80 and over | 14 | 2021 | 1942 | 0.750 |
Why?
|
| Biomedical Research | 1 | 2022 | 75 | 0.750 |
Why?
|
| Professional-Patient Relations | 2 | 2021 | 48 | 0.740 |
Why?
|
| Vital Signs | 1 | 2021 | 12 | 0.730 |
Why?
|
| Risk Management | 1 | 2021 | 4 | 0.710 |
Why?
|
| Adenoma | 1 | 2022 | 95 | 0.710 |
Why?
|
| Patient Participation | 1 | 2022 | 123 | 0.690 |
Why?
|
| Family | 1 | 2021 | 106 | 0.670 |
Why?
|
| Evidence-Based Practice | 2 | 2019 | 55 | 0.660 |
Why?
|
| Strategic Planning | 1 | 2019 | 1 | 0.650 |
Why?
|
| Ambulatory Care | 4 | 2015 | 228 | 0.640 |
Why?
|
| Time Factors | 8 | 2019 | 1044 | 0.630 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 35 | 0.630 |
Why?
|
| Medical Errors | 2 | 2021 | 17 | 0.610 |
Why?
|
| Retrospective Studies | 17 | 2025 | 2428 | 0.610 |
Why?
|
| Internet | 3 | 2019 | 212 | 0.610 |
Why?
|
| Quality Assurance, Health Care | 3 | 2015 | 134 | 0.590 |
Why?
|
| Early Detection of Cancer | 5 | 2025 | 529 | 0.590 |
Why?
|
| Suicide, Assisted | 1 | 2018 | 4 | 0.580 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 17 | 0.580 |
Why?
|
| Terminally Ill | 1 | 2018 | 9 | 0.580 |
Why?
|
| Surgeons | 1 | 2018 | 13 | 0.580 |
Why?
|
| Benchmarking | 1 | 2018 | 41 | 0.570 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 1287 | 0.570 |
Why?
|
| Patient Discharge | 3 | 2017 | 154 | 0.570 |
Why?
|
| Consumer Behavior | 1 | 2018 | 28 | 0.560 |
Why?
|
| Adult | 25 | 2025 | 7529 | 0.550 |
Why?
|
| Primary Health Care | 7 | 2017 | 729 | 0.550 |
Why?
|
| Decision Making | 2 | 2018 | 172 | 0.540 |
Why?
|
| United States | 12 | 2022 | 3891 | 0.540 |
Why?
|
| Disease Management | 3 | 2014 | 127 | 0.540 |
Why?
|
| Publishing | 1 | 2017 | 8 | 0.540 |
Why?
|
| Models, Statistical | 1 | 2018 | 173 | 0.530 |
Why?
|
| Sinusitis | 4 | 2017 | 18 | 0.530 |
Why?
|
| Safety | 1 | 2017 | 43 | 0.530 |
Why?
|
| Electronic Mail | 2 | 2014 | 51 | 0.520 |
Why?
|
| Insurance, Health | 1 | 2018 | 175 | 0.510 |
Why?
|
| Chronic Disease | 2 | 2016 | 405 | 0.500 |
Why?
|
| Patient-Centered Care | 3 | 2015 | 190 | 0.490 |
Why?
|
| Anti-Bacterial Agents | 4 | 2017 | 144 | 0.470 |
Why?
|
| Healthcare Disparities | 3 | 2025 | 205 | 0.450 |
Why?
|
| Diagnosis | 1 | 2014 | 4 | 0.440 |
Why?
|
| Hospital Administration | 1 | 2014 | 5 | 0.440 |
Why?
|
| Vascular Surgical Procedures | 1 | 2014 | 4 | 0.440 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2014 | 1 | 0.440 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2014 | 7 | 0.440 |
Why?
|
| Comprehensive Health Care | 1 | 2013 | 8 | 0.430 |
Why?
|
| Patient Safety | 1 | 2014 | 38 | 0.430 |
Why?
|
| Case Management | 1 | 2014 | 29 | 0.430 |
Why?
|
| Health Status Disparities | 1 | 2015 | 148 | 0.430 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 367 | 0.410 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 17 | 0.390 |
Why?
|
| Risk Factors | 8 | 2025 | 3255 | 0.380 |
Why?
|
| Young Adult | 11 | 2017 | 2473 | 0.370 |
Why?
|
| Registries | 1 | 2014 | 460 | 0.370 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 1155 | 0.360 |
Why?
|
| Learning | 3 | 2023 | 13 | 0.360 |
Why?
|
| Hip Fractures | 2 | 2022 | 72 | 0.340 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2022 | 109 | 0.320 |
Why?
|
| Adolescent | 9 | 2017 | 3533 | 0.310 |
Why?
|
| Social Responsibility | 2 | 2022 | 8 | 0.310 |
Why?
|
| Incidence | 5 | 2020 | 1266 | 0.290 |
Why?
|
| Heart Failure | 1 | 2014 | 404 | 0.290 |
Why?
|
| Glomerulonephritis | 2 | 2018 | 2 | 0.270 |
Why?
|
| Biopsy | 3 | 2022 | 82 | 0.260 |
Why?
|
| Ethnic Groups | 3 | 2020 | 456 | 0.260 |
Why?
|
| Efficiency, Organizational | 2 | 2018 | 27 | 0.250 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 151 | 0.250 |
Why?
|
| Hypercholesterolemia | 1 | 2025 | 24 | 0.240 |
Why?
|
| Safety-net Providers | 1 | 2025 | 55 | 0.230 |
Why?
|
| Documentation | 2 | 2016 | 40 | 0.230 |
Why?
|
| Immunologic Factors | 1 | 2025 | 30 | 0.230 |
Why?
|
| Physicians, Primary Care | 1 | 2025 | 64 | 0.230 |
Why?
|
| Coronary Artery Disease | 1 | 2025 | 112 | 0.220 |
Why?
|
| Treatment Outcome | 3 | 2018 | 1170 | 0.220 |
Why?
|
| Decision Support Systems, Clinical | 3 | 2019 | 53 | 0.220 |
Why?
|
| Clinical Clerkship | 1 | 2023 | 1 | 0.220 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2023 | 4 | 0.220 |
Why?
|
| Communication | 2 | 2016 | 181 | 0.220 |
Why?
|
| Health Services Accessibility | 2 | 2017 | 274 | 0.210 |
Why?
|
| Medicare | 2 | 2017 | 201 | 0.210 |
Why?
|
| Students, Medical | 1 | 2023 | 19 | 0.210 |
Why?
|
| Central Nervous System Agents | 1 | 2023 | 5 | 0.210 |
Why?
|
| Algorithms | 1 | 2025 | 226 | 0.210 |
Why?
|
| Colonoscopy | 2 | 2022 | 257 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2025 | 131 | 0.210 |
Why?
|
| Patient Compliance | 1 | 2025 | 278 | 0.210 |
Why?
|
| Papillomavirus Infections | 1 | 2025 | 142 | 0.210 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2018 | 311 | 0.200 |
Why?
|
| Multiple Sclerosis | 1 | 2025 | 102 | 0.200 |
Why?
|
| Comorbidity | 3 | 2014 | 564 | 0.200 |
Why?
|
| Emergency Service, Hospital | 2 | 2017 | 381 | 0.200 |
Why?
|
| Autopsy | 1 | 2022 | 16 | 0.200 |
Why?
|
| Health Maintenance Organizations | 3 | 2015 | 408 | 0.200 |
Why?
|
| Myocardial Infarction | 2 | 2025 | 225 | 0.190 |
Why?
|
| Medical Records | 1 | 2022 | 93 | 0.190 |
Why?
|
| Family Practice | 1 | 2022 | 41 | 0.190 |
Why?
|
| Referral and Consultation | 2 | 2014 | 160 | 0.190 |
Why?
|
| Laboratories | 1 | 2022 | 19 | 0.190 |
Why?
|
| Hyperkalemia | 1 | 2022 | 16 | 0.190 |
Why?
|
| Empathy | 1 | 2021 | 8 | 0.180 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 44 | 0.180 |
Why?
|
| Dementia | 1 | 2023 | 123 | 0.180 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 53 | 0.180 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 84 | 0.180 |
Why?
|
| Hyponatremia | 1 | 2020 | 5 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2022 | 140 | 0.170 |
Why?
|
| Government Programs | 1 | 2020 | 12 | 0.170 |
Why?
|
| Health Priorities | 1 | 2020 | 24 | 0.170 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 677 | 0.170 |
Why?
|
| Research Personnel | 1 | 2020 | 28 | 0.170 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2020 | 8 | 0.170 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2020 | 7 | 0.170 |
Why?
|
| Prescription Drug Overuse | 1 | 2019 | 4 | 0.170 |
Why?
|
| Polypharmacy | 1 | 2019 | 13 | 0.160 |
Why?
|
| Geriatric Assessment | 1 | 2019 | 43 | 0.160 |
Why?
|
| Occult Blood | 1 | 2021 | 155 | 0.160 |
Why?
|
| Medication Errors | 1 | 2019 | 6 | 0.160 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 66 | 0.160 |
Why?
|
| Self Report | 1 | 2021 | 257 | 0.160 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 12 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2017 | 152 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 203 | 0.150 |
Why?
|
| Advance Directives | 1 | 2018 | 7 | 0.150 |
Why?
|
| Clinical Competence | 2 | 2023 | 93 | 0.150 |
Why?
|
| Circumcision, Male | 1 | 2018 | 1 | 0.150 |
Why?
|
| Thyroidectomy | 1 | 2018 | 2 | 0.150 |
Why?
|
| Hospitals, High-Volume | 1 | 2018 | 3 | 0.150 |
Why?
|
| Disease Progression | 1 | 2019 | 259 | 0.150 |
Why?
|
| Reoperation | 1 | 2018 | 23 | 0.150 |
Why?
|
| Personal Autonomy | 1 | 2018 | 5 | 0.150 |
Why?
|
| Kidney Glomerulus | 1 | 2018 | 1 | 0.150 |
Why?
|
| Hysterectomy | 1 | 2018 | 29 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2018 | 108 | 0.140 |
Why?
|
| Education, Continuing | 1 | 2017 | 5 | 0.140 |
Why?
|
| Antimicrobial Stewardship | 1 | 2017 | 7 | 0.140 |
Why?
|
| Patient Care Management | 1 | 2018 | 26 | 0.140 |
Why?
|
| Hospitalization | 2 | 2020 | 805 | 0.140 |
Why?
|
| Workplace | 1 | 2017 | 29 | 0.140 |
Why?
|
| Craniocerebral Trauma | 1 | 2017 | 11 | 0.140 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 439 | 0.140 |
Why?
|
| Drug Utilization | 1 | 2017 | 122 | 0.130 |
Why?
|
| Attitude to Health | 1 | 2018 | 148 | 0.130 |
Why?
|
| Health Services | 1 | 2017 | 112 | 0.130 |
Why?
|
| Medical Overuse | 1 | 2016 | 14 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2018 | 2526 | 0.130 |
Why?
|
| Hospitals | 1 | 2017 | 76 | 0.130 |
Why?
|
| User-Computer Interface | 1 | 2016 | 21 | 0.130 |
Why?
|
| Health Care Surveys | 2 | 2014 | 218 | 0.130 |
Why?
|
| Physicians, Family | 1 | 2016 | 37 | 0.130 |
Why?
|
| Job Satisfaction | 1 | 2016 | 21 | 0.130 |
Why?
|
| Chronic Pain | 1 | 2017 | 127 | 0.120 |
Why?
|
| Photography | 1 | 2015 | 11 | 0.120 |
Why?
|
| Diabetic Retinopathy | 1 | 2015 | 20 | 0.120 |
Why?
|
| Allied Health Personnel | 1 | 2015 | 12 | 0.120 |
Why?
|
| Health Records, Personal | 1 | 2015 | 10 | 0.120 |
Why?
|
| Insurance Coverage | 1 | 2016 | 103 | 0.120 |
Why?
|
| Program Development | 1 | 2015 | 64 | 0.120 |
Why?
|
| Access to Information | 1 | 2015 | 12 | 0.120 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2015 | 98 | 0.120 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 52 | 0.120 |
Why?
|
| Accelerometry | 1 | 2015 | 51 | 0.110 |
Why?
|
| Organizational Case Studies | 1 | 2014 | 22 | 0.110 |
Why?
|
| Computer Security | 1 | 2014 | 6 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 246 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 174 | 0.110 |
Why?
|
| Continental Population Groups | 1 | 2016 | 289 | 0.110 |
Why?
|
| Walking | 1 | 2015 | 89 | 0.110 |
Why?
|
| Biomarkers | 1 | 2015 | 306 | 0.110 |
Why?
|
| Workload | 1 | 2014 | 26 | 0.110 |
Why?
|
| Awareness | 1 | 2014 | 17 | 0.110 |
Why?
|
| Office Visits | 1 | 2014 | 74 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 59 | 0.110 |
Why?
|
| Psychometrics | 1 | 2014 | 119 | 0.110 |
Why?
|
| Home Care Services | 1 | 2014 | 28 | 0.110 |
Why?
|
| Models, Organizational | 1 | 2013 | 54 | 0.110 |
Why?
|
| Automation | 1 | 2013 | 25 | 0.110 |
Why?
|
| Early Medical Intervention | 1 | 2013 | 10 | 0.110 |
Why?
|
| Aftercare | 1 | 2014 | 48 | 0.100 |
Why?
|
| Survival Rate | 1 | 2014 | 253 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 155 | 0.100 |
Why?
|
| Humanism | 1 | 2013 | 1 | 0.100 |
Why?
|
| Altruism | 1 | 2013 | 2 | 0.100 |
Why?
|
| Health Promotion | 1 | 2016 | 278 | 0.100 |
Why?
|
| Medication Reconciliation | 1 | 2013 | 6 | 0.100 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2013 | 53 | 0.100 |
Why?
|
| Medical Informatics | 1 | 2012 | 35 | 0.100 |
Why?
|
| Telephone | 1 | 2013 | 150 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 1287 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2013 | 275 | 0.090 |
Why?
|
| Sex Factors | 3 | 2020 | 607 | 0.080 |
Why?
|
| Colitis, Microscopic | 1 | 2009 | 1 | 0.080 |
Why?
|
| Age Factors | 3 | 2020 | 884 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2009 | 21 | 0.080 |
Why?
|
| Age Distribution | 2 | 2020 | 239 | 0.070 |
Why?
|
| Focus Groups | 2 | 2016 | 144 | 0.060 |
Why?
|
| Acute Disease | 2 | 2017 | 144 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2025 | 455 | 0.060 |
Why?
|
| Qualitative Research | 2 | 2016 | 262 | 0.060 |
Why?
|
| Papillomaviridae | 1 | 2025 | 61 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2025 | 112 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2025 | 304 | 0.060 |
Why?
|
| Faculty, Medical | 1 | 2023 | 8 | 0.050 |
Why?
|
| Feedback | 1 | 2023 | 20 | 0.050 |
Why?
|
| Logistic Models | 2 | 2017 | 884 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2023 | 7 | 0.050 |
Why?
|
| Life Style | 1 | 2025 | 316 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2023 | 3 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2025 | 165 | 0.050 |
Why?
|
| Rectum | 1 | 2022 | 14 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 21 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2017 | 1229 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 609 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2015 | 306 | 0.040 |
Why?
|
| Sodium | 1 | 2020 | 13 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2020 | 46 | 0.040 |
Why?
|
| Oceanic Ancestry Group | 1 | 2020 | 33 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 180 | 0.040 |
Why?
|
| Asian Americans | 1 | 2020 | 164 | 0.040 |
Why?
|
| Obesity | 1 | 2025 | 814 | 0.040 |
Why?
|
| Hispanic Americans | 1 | 2020 | 378 | 0.040 |
Why?
|
| European Continental Ancestry Group | 1 | 2020 | 480 | 0.040 |
Why?
|
| Inservice Training | 1 | 2017 | 14 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 70 | 0.030 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2017 | 25 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 203 | 0.030 |
Why?
|
| Policy | 1 | 2017 | 19 | 0.030 |
Why?
|
| Deductibles and Coinsurance | 1 | 2017 | 31 | 0.030 |
Why?
|
| African Americans | 1 | 2020 | 443 | 0.030 |
Why?
|
| Health Expenditures | 1 | 2017 | 73 | 0.030 |
Why?
|
| Comprehension | 1 | 2016 | 18 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 77 | 0.030 |
Why?
|
| Health Care Reform | 1 | 2016 | 20 | 0.030 |
Why?
|
| Health Education | 1 | 2016 | 82 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 702 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2015 | 66 | 0.030 |
Why?
|
| Quality Control | 1 | 2015 | 42 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 341 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 36 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 211 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2014 | 30 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 343 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 1162 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 644 | 0.030 |
Why?
|
| Community Health Centers | 1 | 2014 | 64 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 1375 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 36 | 0.030 |
Why?
|
| Prevalence | 1 | 2015 | 839 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 226 | 0.020 |
Why?
|
| Child | 1 | 2017 | 2382 | 0.020 |
Why?
|
| American Recovery and Reinvestment Act | 1 | 2010 | 2 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 1079 | 0.020 |
Why?
|